Feiran Lou to Female
This is a "connection" page, showing publications Feiran Lou has written about Female.
Connection Strength
0.570
-
Reddington H, Emmerick I, Diaz Collante J, Maini A, Kanzaria R, Crawford A, Phillips W, Maxfield M, Uy K, Lou F. Survival following sublobar resection after neoadjuvant therapy for T1N1-2M0 lung cancer. PLoS One. 2026; 21(6):e0349231.
Score: 0.053
-
Reddington H, Shafique S, Palleiko B, Bludevich B, Crawford A, Maxfield M, Uy KF, Emmerick ICM, Lou F. The Modified Frailty Index and Its Association With Esophagectomy Outcomes. J Surg Res. 2026 Aug; 324:20-26.
Score: 0.052
-
Park JJ, Whalen GF, Emmerick ICM, Uy KF, Maxfield MW, Crawford A, Lou F. Textbook Outcomes After Esophagectomy with Gastric Conduit for Cancer: A 2016-2021 National Surgical Quality Improvement Program Analysis. J Surg Res. 2026 Mar; 319:66-76.
Score: 0.051
-
Reddington H, Bogursky A, Ballinger Z, Widdowson K, Guart J, Walter D, Maxfield M, Uy K, Lou F. Robotic Surgery Training During General Surgery Residency: A National Survey Study. J Surg Educ. 2025 11; 82(11):103702.
Score: 0.050
-
Reddington H, Ballinger Z, Guart J, Emmerick I, Crawford A, Maxfield M, Uy K, Lou F. National adoption of robotic-assisted thoracoscopic surgery for oncologic lung resections. J Robot Surg. 2025 Sep 04; 19(1):557.
Score: 0.050
-
Emmerick I, Reddington H, Patil TN, Neamtu A, Guart J, Foley R, Crawford A, Uy K, Maxfield MW, Rabotnikov Y, Phillips W, Lou F. Factors associated with chronic opioid use after minimally invasive lung resections. PLoS One. 2025; 20(6):e0325354.
Score: 0.049
-
Reddington H, Emmerick I, Crawford A, Briskin C, Maxfield M, Uy K, Lou F. Safety and Efficacy of Oncologic Second Pulmonary Resections: A Study of The Society of Thoracic Surgeons General Thoracic Surgery Database. Ann Thorac Surg. 2026 02; 121(2):300-309.
Score: 0.049
-
Palleiko BA, Dickson KM, Crawford A, Shafique S, Emmerick I, Uy K, Maxfield MW, Lou F. Preoperative risk factors for anastomotic leak after esophagectomy with gastric reconstruction: A 6-year national surgical quality improvement (NSQIP) database analysis. Surgery. 2024 07; 176(1):93-99.
Score: 0.046
-
Lou F, Huang J. Reply: To PMID 23915584. Ann Thorac Surg. 2014 Sep; 98(3):1144.
Score: 0.023
-
Lou F, Sima CS, Rusch VW, Jones DR, Huang J. Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung?cancer. Ann Thorac Surg. 2014 Nov; 98(5):1755-60; discussion 1760-1.
Score: 0.023
-
Lou F, Sima CS, Adusumilli PS, Bains MS, Sarkaria IS, Rusch VW, Rizk NP. Esophageal cancer recurrence patterns and implications for surveillance. J Thorac Oncol. 2013 Dec; 8(12):1558-62.
Score: 0.022
-
Lou F, Sarkaria I, Pietanza C, Travis W, Roh MS, Sica G, Healy D, Rusch V, Huang J. Recurrence of pulmonary carcinoid tumors after resection: implications for postoperative surveillance. Ann Thorac Surg. 2013 Oct; 96(4):1156-1162.
Score: 0.022
-
Lou F, Huang J, Sima CS, Dycoco J, Rusch V, Bach PB. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg. 2013 Jan; 145(1):75-81; discussion 81-2.
Score: 0.020
-
Diaz Collante J, Crawford A, Reddington H, Markel A, Epstein M, Gray C, Lou F, Phillips W, Maxfield M, Uy K, Emmerick I. National trends in lung cancer stage, treatment, and time to treatment initiation after a major healthcare disruption (NCDB 2014-2022). J Cancer Policy. 2026 Jun; 48:100724.
Score: 0.013
-
Emmerick ICM, Singh A, Powers M, Lou F, Lin P, Maxfield M, Uy K. Factors associated with diagnosis of stages I and II lung cancer: a multivariate analysis. Rev Saude Publica. 2021; 55:112.
Score: 0.010
-
Emmerick ICM, Uy K, Guiab K, Powers M, Lou F, Lin P, Maxfield M, Voland R, Varlotto J. Impact of the National Lung Screening Trial (NLST) publication and Medicare Lung cancer screening payment on lung cancer incidence rates: An interrupted time series analysis. J Cancer Policy. 2022 03; 31:100318.
Score: 0.010
-
McMillan RR, Berger A, Sima CS, Lou F, Dycoco J, Rusch V, Rizk NP, Jones DR, Huang J. Thirty-day mortality underestimates the risk of early death after major resections for thoracic malignancies. Ann Thorac Surg. 2014 Nov; 98(5):1769-74; discussion 1774-5.
Score: 0.006
-
Ripley RT, McMillan RR, Sima CS, Hasan SM, Ahmad U, Lou F, Jones DR, Rusch VW, Rizk NP, Huang J. Second primary lung cancers: smokers versus nonsmokers after resection of stage I lung adenocarcinoma. Ann Thorac Surg. 2014 Sep; 98(3):968-74.
Score: 0.006
-
Farjah F, Lou F, Sima C, Rusch VW, Rizk NP. A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography. J Thorac Oncol. 2013 Sep; 8(9):1170-80.
Score: 0.005
-
Amini A, Lou F, Correa AM, Baldassarre R, Rimner A, Huang J, Roth JA, Swisher SG, Vaporciyan AA, Lin SH. Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgery. Ann Surg Oncol. 2013 Jun; 20(6):1934-40.
Score: 0.005
-
Farjah F, Lou F, Rusch VW, Rizk NP. The quality metric prolonged length of stay misses clinically important adverse events. Ann Thorac Surg. 2012 Sep; 94(3):881-7; discussion 887-8.
Score: 0.005